摘要
目的:分离鉴定双黄连粉针剂中的化学成分,丰富了双黄连粉针剂的物质基础,为阐释该制剂的致敏成分组和二次开发奠定了基础。方法:双黄连冻干粉通过大孔吸附树脂AB-8,反复硅胶柱色谱,反相ODS和制备HPLC等多种方法进行分离纯化,利用理化性质及MS,1D NMR,2D NMR等波谱学方法鉴定结构。结果:分离鉴定了7个化合物,分别是连翘脂素(1),千层纸素A(2),(+)-表松脂素-4'-O-β-D-吡喃葡萄糖苷(3),异落叶松脂醇(4),千层纸素A-7-O-β-D-葡萄糖醛酸苷甲酯(5),Chrysin-7-glucuronide methyl ester(6)和咖啡酸乙酯(7)。结论:化合物1~7均是首次从该复方得到,且化合物6和7在双黄连粉针的原料金银花、黄芩、连翘也未见报道。
Objective: To study the chemical constituents from Shuanghuanglian poder for injection. Methods: The constituents were isolated and purified by silica gel,ODS,and Sephadex LH- 20 column chromatographies as well as HPLC. Their chemical structures were elucidated on the basis of spectral data. Results: The compounds were isolated from the MeOH fraction of Shuanghuanglian poder for injection and identified as Phillygenin( 1),Oroxylin- A( 2),( +)-epipinoresino- 4'- β- D-- glueoside( 3),Isolariciresinol( 4),oroxylinA- 7- O- β- D- glucuronide( 5),Chrysin- 7- glucuronide methyl ester( 6). Caffeicacide- thylester( 7). Conclusion: Compounds 1 ~ 7 are isolated from Shuanghuanglian injection for the first time,and compounds 6 and 7 have not been isolated from Scutellariae Radix,Forsythiae Fructusand and Lonicera japonicae Flos.
出处
《中医药学报》
CAS
2014年第1期12-15,共4页
Acta Chinese Medicine and Pharmacology
基金
"重大新药创制"科技重大专项-双黄连粉针剂技术改造(2011ZX09201-201-15)
北京中医药大学创新团队资助项目(2011-CXTD-15)